no Thymol is not a bacteriophage but rather a natural compound that is found in thyme. We chose it as our compound because it had been previously shown to have anitmicrobial properties outside of being a virus
I believe our experiement didn’t yield our desired outcome because the concentration of the thymol was not strong enough. Since it had been shown to have antibacterial properties based on prior research, it is proven that it can be effective, but I think that because there was a limit to how concentrated it could be based on human tolerability, that we could not bring it up to the required concentration in order to get the desired effect even though we tested it way above the tolerable dose in humans.
You’re presentation was super good! My only question is if you had received your desired outcome, what would be the steps to get this idea into human testing and use?
If we had received the desired outcome in our research, the next steps would be to have our compound be tested in in vitro studies against bacteria to further preclinical testing of thymol. This would help us to see how thymol would act against bacteria in a human cell and find the tolerable dose since we only tested how it worked against salmonella bacteria in general.
Is Thymol a bacteriophage?
no Thymol is not a bacteriophage but rather a natural compound that is found in thyme. We chose it as our compound because it had been previously shown to have anitmicrobial properties outside of being a virus
Why do you think you experiment didn’t yield your ideal outcome?
I believe our experiement didn’t yield our desired outcome because the concentration of the thymol was not strong enough. Since it had been shown to have antibacterial properties based on prior research, it is proven that it can be effective, but I think that because there was a limit to how concentrated it could be based on human tolerability, that we could not bring it up to the required concentration in order to get the desired effect even though we tested it way above the tolerable dose in humans.
You’re presentation was super good! My only question is if you had received your desired outcome, what would be the steps to get this idea into human testing and use?
If we had received the desired outcome in our research, the next steps would be to have our compound be tested in in vitro studies against bacteria to further preclinical testing of thymol. This would help us to see how thymol would act against bacteria in a human cell and find the tolerable dose since we only tested how it worked against salmonella bacteria in general.